Calcium + D3.

Vitamin K2 carboxylates osteocalcin and matrix Gla protein, the two proteins that bind calcium into bone matrix and hold it out of soft tissue. Calcium with D3 raises absorbed calcium, and K2 governs where that calcium is deposited.

The liver and kidney enzymes that hydroxylate vitamin D3 to 25-OH-D and then to calcitriol are magnesium dependent, and parathyroid hormone release also needs magnesium. Low magnesium blunts the calcium handling that a D3 pairing is meant to drive.

Calcium taken in the same dose reduces non-heme iron uptake, since both move through overlapping divalent transport at the brush border. Standard practice separates a calcium dose from an iron dose by several hours.

Large calcium doses lower fractional zinc absorption by competing for the same divalent uptake route and by shifting luminal ligand binding. Spacing the two doses keeps both minerals available.

Strontium is absorbed by the same calcium pathways and incorporates into the same hydroxyapatite sites, so a large calcium dose lowers strontium uptake and the same holds in the other direction. Formulators separate them rather than combining them in one dose.

Bone is mineralised collagen, and ascorbate is the cofactor for the prolyl and lysyl hydroxylases that build a stable collagen triple helix. Calcium and D3 supply the mineral phase while vitamin C supports the protein scaffold it deposits onto.

Sodium and calcium share reabsorption in the renal tubule, so a high sodium load raises urinary calcium loss. A calcium and D3 dose taken against a heavy sodium intake retains less of what it absorbs.

Caffeine produces a modest, measurable rise in urinary calcium in the hours after intake. The effect is small against adequate calcium intake and matters most when intake is already low.

Boron intake is associated with reduced urinary excretion of calcium and magnesium and with altered vitamin D metabolite levels. It sits alongside calcium and D3 as a mineral-retention factor rather than a source of mineral.

Orthosilicic acid influences collagen synthesis and early mineralisation at the bone matrix interface in cell and animal work. It acts on matrix quality rather than on calcium supply, and the size of the effect in people is not settled.

A large viscous fibre dose slows and binds divalent minerals in the gut lumen, lowering calcium uptake from a co-taken dose. Separating the fibre from the mineral dose avoids the loss.

Osteocalcin and matrix Gla protein only bind calcium once their glutamate residues are gamma-carboxylated, and that reaction requires vitamin K as the cofactor. Vitamin D drives osteocalcin production; vitamin K determines whether the protein made can hold calcium at all. Phylloquinone is the dietary form with the shortest half-life, which is why it is often paired at higher frequency than a menaquinone.

Bone mineral is calcium phosphate in the hydroxyapatite lattice, so calcium without phosphate has nothing to crystallise with. Active vitamin D raises intestinal absorption of both minerals together. In ordinary diets phosphorus is abundant, so the practical concern is ratio rather than shortfall.

Cholecalciferol is a fat-soluble secosteroid absorbed with dietary lipid through micelle formation and chylomicron packaging. A lipid vehicle in the capsule or a meal containing fat both serve that step. Absorption of a dry format varies more with what is eaten alongside it, since the lipid has to come from the meal.

The vitamin D receptor signals as a heterodimer with the retinoid X receptor, and high preformed retinol shifts that shared partner toward retinoid signalling. Observational work links high preformed retinol intake with lower bone mineral density, which is an association and not a demonstrated cause. Beta-carotene does not carry the same concern because conversion is regulated.

Fermentable fructans are converted by colonic bacteria to short-chain fatty acids, dropping luminal pH and keeping calcium in a soluble ionised state where paracellular uptake can still occur past the small intestine. Human balance studies using stable isotopes report increased fractional calcium absorption with inulin-type fructans. The effect is on absorption, a measurement, rather than on any bone outcome directly.

Short-chain fructooligosaccharides ferment quickly in the proximal colon, lowering pH and improving calcium solubility at the point of colonic uptake. Isotope-tracer absorption work supports the effect in adolescents in particular. Gas and bloating at higher doses is the practical limit.

Galactooligosaccharides are fermented more distally than fructans and produce the same acidifying short-chain fatty acids. Reported calcium absorption gains are in the same direction as the fructan data. Less human absorption work exists specifically for GOS, hence the lower confidence.

Resistant starch reaches the colon intact and is fermented to butyrate and other short-chain fatty acids, acidifying the lumen the same way fructans do. That keeps calcium soluble where it would otherwise precipitate. The link to measured calcium absorption in humans is thinner than for inulin.

Calcium carbonate must be dissolved by gastric acid before the calcium ion is available for absorption, which is why it is directed to be taken with food. Where gastric acid output is low, that dissolution step is the bottleneck. Calcium citrate does not depend on it, so this interaction applies to the carbonate form specifically.

Phytate in grains and legumes binds calcium in the gut lumen and carries it out unabsorbed. Phytase hydrolyses the phosphate groups that do the binding and releases the mineral. The effect is largest in high-phytate meals and negligible in a low-phytate one.

Non-heme iron and calcium compete at the enterocyte, and a large calcium dose taken with iron reduces iron uptake from the same meal. Chelated iron forms such as bisglycinate use a partly separate route and are affected less than a simple iron salt, though not zero. Spacing the two doses by a couple of hours is the standard formulation answer.

Large single calcium doses reduce the fractional absorption of other divalent minerals sharing intestinal transport, copper among them. The effect scales with the calcium dose, not with the presence of calcium as such. Splitting calcium into smaller doses reduces the concern and also improves calcium absorption itself.

Manganese uptake falls when a large calcium dose shares the meal, through the same divalent transporter competition that affects iron and copper. This is a dose-timing matter rather than a reason to avoid either. Manganese requirements are small, so the practical significance is modest in a mixed diet.

Bone is roughly half protein by volume, and adequate dietary protein supports both the collagen matrix and intestinal calcium absorption. Higher protein intakes raise urinary calcium while also raising absorption, so the net balance is generally neutral to favourable when calcium intake is adequate. The pairing matters most where protein intake is low.

Type I collagen is the scaffold that bone mineral crystallises onto, and collagen peptides supply the glycine, proline and hydroxyproline that scaffold is built from. Calcium and vitamin D address the mineral half of the same tissue. Supplying substrate is not the same as demonstrating a bone outcome, and that distinction should stay visible.

Lysine has been reported to increase intestinal calcium absorption and reduce urinary calcium loss in small human studies. It is also a substrate for collagen crosslinking through lysyl oxidase. The human evidence base is small and old, which is why this stays early.

Phospholipid emulsifiers help disperse cholecalciferol into micelles, the step that has to happen before absorption. This is a formulation effect rather than a nutrient interaction. It matters most in low-fat delivery formats such as a chewable or a water-dispersible powder.

Activated charcoal adsorbs a wide range of compounds in the gut without selectivity, and a fat-soluble vitamin taken at the same time can be carried out with it. Minerals are less affected than lipophilic molecules but the timing rule is the same. Separate the doses by several hours.

Bentonite is a cation-exchange material and binds divalent cations including calcium in the gut lumen. Taken together, part of a calcium dose is exchanged onto the clay and lost. This is a dose-separation issue rather than a contraindication.

Uptake of the intrinsic factor and B12 complex by the cubilin-amnionless receptor in the terminal ileum is calcium-dependent. Where luminal calcium availability is reduced, that specific uptake step suffers. This is a well-described piece of absorption biochemistry rather than a reason to dose the two together.